SENATE 708118th CongressRead twice and referred to the Committee on Finance.
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
- Last Action
- 3/8/2023
Actions
- 2023-03-08Read twice and referred to the Committee on Finance.
- 2023-03-08Introduced in Senate
CRS Summary
As of 2023-03-08 (00)
This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.
Cosponsors (2)
- Tim Scott (R-SC)
- Marsha Blackburn (R-TN)
Subjects
- Drug therapy
- Medicaid
- Mental health
- Prescription drugs
- State and local government operations
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.